Carl Zeiss Meditec AG
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for ret… Read more
Market Cap & Net Worth: Carl Zeiss Meditec AG (CZMWF)
Carl Zeiss Meditec AG (PINK:CZMWF) has a market capitalization of $6.02 Billion ($6.02 Billion) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #4676 globally and #2886 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Carl Zeiss Meditec AG's stock price $68.73 by its total outstanding shares 87536079 (87.54 Million).
Carl Zeiss Meditec AG Market Cap History: 2016 to 2025
Carl Zeiss Meditec AG's market capitalization history from 2016 to 2025. Data shows growth from $3.01 Billion to $6.02 Billion (9.70% CAGR).
Carl Zeiss Meditec AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Carl Zeiss Meditec AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.30x
Carl Zeiss Meditec AG's market cap is 2.30 times its annual revenue
169.88x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
42.61x
Carl Zeiss Meditec AG's market cap is 42.61 times its annual earnings
830.37x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $3.01 Billion | $1.09 Billion | $98.33 Million | 2.76x | 30.60x |
| 2017 | $5.19 Billion | $1.19 Billion | $134.44 Million | 4.36x | 38.60x |
| 2018 | $6.74 Billion | $1.28 Billion | $126.46 Million | 5.26x | 53.26x |
| 2019 | $10.81 Billion | $1.46 Billion | $159.76 Million | 7.41x | 67.70x |
| 2020 | $11.46 Billion | $1.34 Billion | $122.39 Million | 8.58x | 93.62x |
| 2021 | $18.11 Billion | $1.65 Billion | $236.28 Million | 11.00x | 76.66x |
| 2022 | $10.83 Billion | $1.90 Billion | $293.91 Million | 5.69x | 36.86x |
| 2023 | $9.39 Billion | $2.09 Billion | $290.40 Million | 4.50x | 32.34x |
| 2024 | $5.36 Billion | $2.07 Billion | $178.73 Million | 2.59x | 29.98x |
| 2025 | $6.02 Billion | $2.61 Billion | $141.21 Million | 2.30x | 42.61x |
Competitor Companies of CZMWF by Market Capitalization
Companies near Carl Zeiss Meditec AG in the global market cap rankings as of March 19, 2026.
Key companies related to Carl Zeiss Meditec AG by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $168.62 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #261 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #358 globally with a market cap of $61.21 Billion USD ( €59.64 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #481 globally with a market cap of $44.89 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $168.62 Billion | $477.73 |
| #261 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #358 | EssilorLuxottica S. A. | PA:EL | $61.21 Billion | €203.10 |
| #481 | Becton Dickinson and Company | NYSE:BDX | $44.89 Billion | $158.08 |
Carl Zeiss Meditec AG Historical Marketcap From 2016 to 2025
Between 2016 and today, Carl Zeiss Meditec AG's market cap moved from $3.01 Billion to $ 6.02 Billion, with a yearly change of 9.70%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $6.02 Billion | +12.27% |
| 2024 | $5.36 Billion | -42.94% |
| 2023 | $9.39 Billion | -13.30% |
| 2022 | $10.83 Billion | -40.20% |
| 2021 | $18.11 Billion | +58.10% |
| 2020 | $11.46 Billion | +5.94% |
| 2019 | $10.81 Billion | +60.57% |
| 2018 | $6.74 Billion | +29.80% |
| 2017 | $5.19 Billion | +72.45% |
| 2016 | $3.01 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Carl Zeiss Meditec AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.02 Billion USD |
| MoneyControl | $6.02 Billion USD |
| MarketWatch | $6.02 Billion USD |
| marketcap.company | $6.02 Billion USD |
| Reuters | $6.02 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.